Theranos Under Investigation By SEC, US Attorney's Office
Law360, Los Angeles (April 18, 2016, 7:28 PM EDT) -- Blood-testing company Theranos Inc. has come under investigation by the U.S. Securities and Exchange Commission and the U.S. attorney’s office in the wake of news reports critical of its technologies and performance, the Palo Alto, California-based company said Monday in an internal memo sent to its “partners.”
In a memo titled “Regulatory Update,” the health care technology startup said probes have been initiated by the U.S. Securities Exchange Commission and the U.S. Attorney's Office for the Northern District of California.
“The investigations by the SEC and the U.S. Attorney's Office, which began following the publication of certain news articles,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!